Based on prior work, we hypothesized that females would exhibit better clinical outcomes than males given their NfL concentration, suggestive of possible “cognitive resilience.” These data support efforts toward more precise dementia care with specific attention to previously understudied aspects of women's brain health that will be critical to consider as novel biomarkers and therapies are developed for FTD. The gene discussed is NEFL; the disease is frontotemporal dementia.